Page last updated: 2024-10-23

aurintricarboxylic acid and Plague

aurintricarboxylic acid has been researched along with Plague in 2 studies

Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.

Plague: An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuban-Jankowska, A1
Sahu, KK1
Niedzialkowski, P1
Gorska, M1
Tuszynski, JA1
Ossowski, T1
Wozniak, M1
Liang, F1
Huang, Z1
Lee, SY1
Liang, J1
Ivanov, MI1
Alonso, A1
Bliska, JB1
Lawrence, DS1
Mustelin, T1
Zhang, ZY1

Other Studies

2 other studies available for aurintricarboxylic acid and Plague

ArticleYear
Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis.
    Oncotarget, 2015, Jul-30, Volume: 6, Issue:21

    Topics: Algorithms; Aurintricarboxylic Acid; Bacterial Outer Membrane Proteins; Humans; Kinetics; Molecular

2015
Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague.
    The Journal of biological chemistry, 2003, Oct-24, Volume: 278, Issue:43

    Topics: Aurintricarboxylic Acid; Bacterial Outer Membrane Proteins; Drug Evaluation, Preclinical; Humans; In

2003